Patent Yard Sign in
Canadian application, no grantCanada

Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies

CA 2429987 A1 · Owner: Taylor, Ronald · Inventors: Sokoloff, Mitchell H.; Nardin, Alessandra; Sutherland, William M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invetion relates to mehtods of treating and preventing cancer in an animal comprising administrating to said animal antibodies specific for C3b(i). The present invention also realtes to mehtods of treating and preventing cancer in an animal comprising administering to said animal IgG antbodies, IgM antibodies and/or complement components in combination with antibodies immunospecifically bind to one or more cancer cell antigens in combination with antibodies immunospecific for C3b(i). The present invention further relates to pharmaceutical compositions for the treatment and prevention of cancer comprising one or more antibodies immunospecific for C3b(i) and one or more …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 28, 2001
GrantedNo grant recorded
Term endedNovember 28, 2021
Patent numberCA 2429987 A1
Classification (IPC)A61K48/00 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedNov 28, 2001Term endedNov 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.